Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CUE

Cue Biopharma Inc

Apr 28 • 04:00PM ET

12.45

-5.48 -30.54 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: AMGN BMY GILD BMRN REGN BIIB VRTX INCY SAGE FATE

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-9.40	Insider Own	0.56%	Shs Outstand	3.26M	Perf Week	-38.03%
Market Cap	40.55M	Forward P/E	-	EPS next Y	-18.00	Insider Trans	-	Shs Float	3.24M	Perf Month	73.42%
Enterprise Value	17.61M	PEG	-	EPS next Q	-	Inst Own	22.31%	Short Float	7.76%	Perf Quarter	6.29%
Income	-26.60M	P/S	1.48	EPS this Y	-107.14%	Inst Trans	-	Short Ratio	0.74	Perf Half Y	-47.13%
Sales	27.47M	P/B	1.52	EPS next Y	-3.45%	ROA	-70.62%	Short Interest	0.25M	Perf YTD	35.94%
Book/sh	8.21	P/C	1.49	EPS next 5Y	-	ROE	-121.11%	52W High	30.97 -59.78%	Perf Year	-47.45%
Cash/sh	8.34	P/FCF	-	EPS past 3/5Y	42.63% 29.04%	ROIC	-92.63%	52W Low	4.97 150.55%	Perf 3Y	-90.41%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	180.45% 54.16%	Gross Margin	95.89%	Volatility	51.68% 41.00%	Perf 5Y	-96.62%
Dividend TTM	-	EV/Sales	0.64	EPS Y/Y TTM	58.21%	Oper. Margin	-96.56%	ATR (14)	4.91	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.74	Sales Y/Y TTM	195.75%	Profit Margin	-96.85%	RSI (14)	47.64	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.74	EPS Q/Q	111.21%	SMA20	-9.34%	Beta	2.09	Target Price	120.00
Payout	-	Debt/Eq	0.16	Sales Q/Q	1292.26%	SMA50	17.88%	Rel Volume	2.12	Prev Close	17.93
Employees	29	LT Debt/Eq	0.09	Earnings	Mar 16 AMC	SMA200	-25.41%	Avg Volume	339.12K	Price	12.45
IPO	Jan 02, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	111.11% 2094.20%	Trades		Volume	698,080	Change	-30.54%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)